MA-DESKTOP-METAL
18.6.2024 14:31:33 CEST | Business Wire | Press release
Desktop Metal (NYSE: DM), a global leader in Additive Manufacturing 2.0 technologies for mass production, today announced that platinum is now a customer-qualified material on the Production System™ P-1 with a specialty powder developed by Legor.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240618795152/en/
Platinum jewelry designs 3D printed by Legor on a Desktop Metal Production System P-1 are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles. The Legor parts to be shown include including a classic wedding band, a gemstone ring, and an intricate leaf earring. (Photo: Business Wire)
Legor is a full-service jewelry manufacturing solutions provider, and the company’s Powmet line of certified ultra-pure metal powders is produced for use with both laser and binder jet 3D printing systems.
“The qualification of Legor’s Powmet platinum on the Production System P-1 is another major milestone for binder jet 3D printing for the jewelry, watchmaking, and luxury goods industry,” said Ric Fulop, Founder and CEO of Desktop Metal. “Platinum is known to be a challenging-to-process material in the jewelry industry because of its high hardness and melting point. Our binder jet 3D printing process simplifies platinum production and enables all-new, once-impossible designs.”
”Legor is currently experiencing significant market interest in 3D printing technology, specifically in binder jet technology,” added Fabio Di Falco, Marketing and Customer Support Manager at Legor. “This has led us to address a variety of requests, ranging from prototyping to small batch production, as well as larger production runs. Thanks to binder jet 3D printing technology, designers can finally imagine and create objects that are currently unproducible with other technologies, thus expanding the boundaries of creativity to shape the future. At Legor, we are committed to becoming catalysts for innovation and promoting technology we are convinced represents a crucial turning point for our industry.”
Platinum jewelry designs 3D printed by Legor — including a classic wedding band, a gemstone ring, and an intricate leaf earring — are slated to be part of a multi-material, multi-customer jewelry display featured by Desktop Metal at Rapid + TCT, North America’s largest additive manufacturing and industrial 3D printing event, to be held June 25-27 in Los Angeles.
Binder Jet 3D Printing for Jewelry and Watchmaking
In 2023, Legor invested in a Desktop Metal Production System P-1, a high-speed, 1-liter binder jet 3D printing system featuring Single Pass Jetting (SPJ) technology. The experienced jewelry manufacturer notes that binder jet 3D printing technology offers several benefits over traditional manufacturing methods and other forms of 3D printing for jewelry production including:
- Rapid production of jewelry samples without molds or printing supports
- All-new design freedom for fast, affordable production of hollow, interlinked, intricate, and mass customized designs
- Elimination of processing steps associated with jewelry designs, such as welding
- Simplified production of materials that are difficult to work with, such as platinum, which often requires special tools
- Low waste production that is eco-friendly and uses only the necessary amount of metal needed to create the design
Legor’s Di Falco noted that sustainability is an important feature of binder jet 3D printing technology for the jewelry industry and Legor specifically.
“Binder jet 3D printing technology represents a significant step toward more sustainable production,” he noted, “enabling energy efficiency, and reducing the amount of material used. Indeed, binder jetting uses exactly the amount of material necessary to create an object, drastically reducing waste. The metal powder not used in the process can be reused, reducing the need for new raw materials and the risks associated with metal extraction. At Legor, we advocate for 3D printing as a responsible production approach that also considers the planet and people.”
A video by Legor showing the benefits of binder jetting platinum jewelry can be viewed at https://legor.com/en/prodotto/platinum-3d-printing/.
For more information about binder jetting jewelry with DM technologies, visit TeamDM.com/jewelry.
About Desktop Metal
Desktop Metal (NYSE:DM) is driving Additive Manufacturing 2.0, a new era of on-demand, digital mass production of industrial, medical, and consumer products. Our innovative 3D printers, materials, and software deliver the speed, cost, and part quality required for this transformation. We’re the original inventors and world leaders of the 3D printing methods we believe will empower this shift, binder jetting and digital light processing. Today, our systems print metal, polymer, sand and other ceramics, as well as foam and recycled wood. Manufacturers use our technology worldwide to save time and money, reduce waste, increase flexibility, and produce designs that solve the world’s toughest problems and enable once-impossible innovations. Learn more about Desktop Metal and our #TeamDM brands at www.desktopmetal.com.
Forward-looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical facts contained in these communications, including statements regarding Desktop Metal’s future results of operations and financial position, financial targets, business strategy, and plans and objectives for future operations, are forward-looking statements. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: risks associated with the integration of the business and operations of acquired businesses; Desktop Metals’ ability to realize the benefits from cost saving measures; supply and logistics disruptions, including shortages and delays. For more information about risks and uncertainties that may impact Desktop Metal’s business, financial condition, results of operations and prospects generally, please refer to Desktop Metal’s reports filed with the SEC, including without limitation the “Risk Factors” and/or other information included in the Form 10-Q filed with the SEC on August 3, 2023, and such other reports as Desktop Metal has filed or may file with the SEC from time to time. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240618795152/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
